The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt – produced an alarming review of the neurological System Organ Class (SOC) adverse events found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., “5.3.6“). This SOC includes altered function of the brain, spinal cord, or peripheral nerves.
It is important to note that the adverse events (AEs) in the 5.3.6 document were reported to Pfizer for only a 90-day period starting on December 1, 2020, the date of the United Kingdom’s public rollout of Pfizer’s COVID-19 experimental mRNA “vaccine” product.
Key points in this report include:
- 542 neurological events, 95% of which were serious, occurred in 501 patients.
- 16 patients died.
- 50% of events occurred within the first 24 hours after injection, equating to over 270 events in a single day.
- 69% of the neurological events affected females, and 31% occurred in males.
- 376 seizures were reported, twelve of which were “status epilepticus,” a rare condition of prolonged seizure or series of seizures that is life-threatening.
- 38 cases of multiple sclerosis.
- 11 cases of transverse myelitis (a destructive inflammation of the spinal cord).
- 10 cases of optic neuritis (inflammation of the optic nerve threatening blindness).
- 24 cases of Guillain-Barré syndrome, ascending paralysis from nerve inflammation.
- Three cases of meningitis (infection and inflammation of the fluid and membranes surrounding the brain and spinal cord).
- Seven cases of encephalopathy (any disease of the brain that alters brain function or structure; hallmark is altered mental state).
- Only adverse events that occurred two or more times are specifically reported in the diagnoses list. There were twenty events that happened once and, thus, were not included.